The activities linked to the fishing sector generate substantial quantities of by-products, which are often discarded or used as low-value ingredients in animal feed. However, these marine by-products are a prominent potential good source of bioactive compounds, with important functional properties that can be isolated or up-concentrated, giving them an added value in higher end markets, as for instance nutraceuticals and cosmetics. This valorization of fish by-products has been boosted by the increasing awareness of consumers regarding the relationship between diet and health, demanding new fish products with enhanced nutritional and functional properties. To obtain fish by-product-derived biocompounds with good, functional and acceptable organoleptic properties, the selection of appropriate extraction methods for each bioactive ingredient is of the outmost importance. In this regard, over the last years, innovative alternative technologies of intensification, such as ultrasound-assisted extraction (UAE) and supercritical fluid extraction (SFE), have become an alternative to the conventional methods in the isolation of valuable compounds from fish and shellfish by-products. Innovative green technologies present great advantages to traditional methods, preserving and even enhancing the quality and the extraction efficiency, as well as minimizing functional properties’ losses of the bioactive compounds extracted from marine by-products. Besides their biological activities, bioactive compounds obtained by innovative alternative technologies can enhance several technological properties of food matrices, enabling their use as ingredients in novel foods. This review is focusing on analyzing the principles and the use of UAE and SFE as emerging technologies to valorize seafoods and their by-products.
Microalgae, as primary producers of EPA and DHA, are among the most prominent alternative sources to fish oil for n-3 long-chain PUFA in animal and human nutrition. The present study aimed to assess technical, nutritional and fish health aspects of producing n-3-rich Atlantic salmon (Salmo salar) fish fillets by dietary supplementation of increasing levels of a DHA-producing Schizochytrium sp. and reduced or without use of supplemental fish oil. Atlantic salmon smolt were fed diets with graded levels of microalgae for 12 weeks, during which all fish showed high feed intake rates with postprandial plasma leptin levels inversely correlating with final mean fish body weights. Fish performance was optimal in all experimental treatments (thermal growth coefficient about 4·0 and feed conversion ratio 0·8–0·9), protein digestibility was equal in all diets, whereas dietary lipid digestibility inversely correlated with the dietary levels of the SFA 16 : 0. Fillet quality was good and similar to the control in all treatments in terms of n-3 long-chain PUFA content, gaping, texture and liquid losses during thawing. Histological fluorescence staining and immunofluorescence analysis of salmon intestines (midgut: base of intestine and villi) revealed significant effects on slime, goblet cell production and inducible nitric oxide synthase (iNOS) activity with increasing levels of dietary Schizochytrium sp. supplementation. Microarray analysis did not reveal any signs of toxicity, stress, inflammation or any other negative effects from Schizochytrium sp. supplementation in diets for Atlantic salmon.
Aquaculture contributes to global food security but sustainable aquaculture development in terms of biodiversity impacts requires the establishment of viable solutions in replacement of the fisheries-based components in aquafeeds. In the current work, pit-tagged Atlantic salmon individuals were grown, from fresh water (18 g body weight) to salt water in tanks (up to 800 g body weight), on diets with low fish meal (FM) (10%) and 1–1.25% total n-3 LC-PUFA levels balanced across the experimental diets. Dietary n-3 LC-PUFAs were supplemented by (1) fish oil (FO), (2) Schizochytrium limacinum biomass (ScB), or (3) a mix of the two (FO/ScB). Further, the fish from all treatments were mixed and redistributed in sea cages reared to slaughter (ca. 3 kg body weight) on either FO or ScB. As FO was rich in both EPA and DHA and ScB was rich in DHA and nearly devoid of EPA, the experimental diets differed significantly in DHA/EPA ratio (0.8 vs. 10.5 in average for FO and ScB, respectively). ScB treatment fish grew to significantly higher body weight in the end of the experiment (2.8 kg vs. 3.3 kg, for FO and ScB, respectively) but similar FCR, survival rate, and biometric indexes compared to the FO groups. ScB fish contained higher levels of EPA + DHA in the filet but lower in the liver, and better filet pigmentation already from the tank phase of the experiment as determined chemically, by salmonfan and a trained sensory panel, and lower prevalence of melanin spots at slaughter. The trained sensory panel found no differences in flavor or odor in the filets from the different dietary groups; however, filets in the FO group were perceived as softer and juicier compared to ScB. The pre-diets up to 800 g body weight had minor effects on fish performance. Global transcriptomics in liver and intestinal tissues revealed significant dietary effects on the expression of immune modulating, as well as ion, lipid, protein, and xenobiotic metabolism genes.
1 May 2010 in Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology